Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-25

Clinical Trial Update: Neurofeedback in Individuals With Substance Use Disorders [NA]

View source ↗

Summary

The Yale-sponsored trial evaluating neurofeedback for opioid use disorder was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Opioid-Related Disorders | NA | Status: TERMINATED | Results posted: 2024-09-25